Cocrystal Pharma's total assets for Q2 2025 were $8.51M, a decrease of -20.21% from the previous quarter. COCP total liabilities were $3.17M for the fiscal quarter, a -5.45% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.